| Pharmaceutical Information |
| Drug Name |
Mecamylamine |
| Drug ID |
BADD_D01356 |
| Description |
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. |
| Indications and Usage |
For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension |
| Marketing Status |
approved; investigational |
| ATC Code |
C02BB01 |
| DrugBank ID |
DB00657
|
| KEGG ID |
Not Available
|
| MeSH ID |
D008464
|
| PubChem ID |
4032
|
| TTD Drug ID |
D0V8HA
|
| NDC Product Code |
Not Available |
| UNII |
6EE945D3OK
|
| Synonyms |
Mecamylamine |
|
| Chemical Information |
| Molecular Formula |
C11H21N |
| CAS Registry Number |
60-40-2 |
| SMILES |
CC1(C2CCC(C2)C1(C)NC)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
